Melinda Miller-Thrasher, MD
Obstetrics & Gynecology · Atlanta, GANPI 1811989965
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (59.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Sumitomo Pharma America, Inc. at 48.7% of the total. Reporting peaked in 2023 at $1,845 and has fallen 71.6% since, to $525 in 2025.
Across 83 payments — averaging $42.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$2K
- AbbVie$356
- Astellas Pharma US Inc$319
- Conmed Corporation$172
- Hologic Sales And Service, LLC$166
- Mayne Pharma Commercial LLC$115
- plus $698 from 20 others
Across 188 payments — averaging $3153.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Exact Sciences$195K
- GSK$143K
- Sumitomo Pharma America, Inc.$141K
- AbbVie$83K
- Myovant Sciences GmbH$30K
What the payments were for
- Travel & lodging$1,27636%
- Food & beverage$2,10459%
- Education$1765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $1,731 |
| AbbVie | 22 | $356 |
| Astellas Pharma US Inc | 9 | $319 |
| Conmed Corporation | 1 | $172 |
| Hologic Sales And Service, LLC | 3 | $166 |
| Mayne Pharma Commercial LLC | 6 | $115 |
| Evofem Biosciences, Inc. | 6 | $92 |
| Channel Medsystems, Inc. | 1 | $80 |
| Shield Therapeutics Inc | 3 | $50 |
| Coopersurgical, Inc. | 2 | $49 |
| Optumhealth Care Solutions, LLC | 2 | $45 |
| Revance Therapeutics, Inc. | 1 | $44 |
| Scynexis, Inc. | 2 | $41 |
| Myovant Sciences Inc. | 2 | $41 |
| Therapeuticsmd, Inc. | 3 | $41 |
| Pfizer | 2 | $34 |
| Bayer | 1 | $23 |
| Millicent US Inc | 1 | $20 |
| Merck | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $19 |
| Acelrx Pharmaceuticals, Inc. | 1 | $18 |
| Trevena, Inc. | 1 | $18 |
| Eagle Pharmaceuticals, Inc. | 1 | $18 |
| LSI Solutions Inc | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Novo Nordisk | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$1,658
- AIRSEAL$172
- ACESSA PROVU SYSTEM$120
How this compares
$3,556 in reported general payments places this provider in the 85th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Atlanta
- Renee AllenAtlanta$74K
- Tosha Rogers-JonesAtlanta$46K
- Tracey LemonAtlanta$36K
- Nisha LakhiAtlanta$27K
- Stephen BlankAtlanta$15K
- Ashley DavisAtlanta$15K
- Nidhi deAtlanta$13K
- Michael DawsonAtlanta$9K
- Desiree McCarthy KeithAtlanta$9K
- Melissa KottkeAtlanta$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.